Edgestream Partners L.P. boosted its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 19.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 15,433 shares of the financial services provider’s stock after buying an additional 2,535 shares during the period. Edgestream Partners L.P.’s holdings in CME Group were worth $4,558,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Asset Dedication LLC lifted its holdings in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 37 shares during the period. Northwestern Mutual Investment Management Company LLC boosted its position in shares of CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after acquiring an additional 37 shares during the last quarter. Rehmann Capital Advisory Group boosted its position in shares of CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after acquiring an additional 37 shares during the last quarter. Sovran Advisors LLC grew its holdings in CME Group by 3.5% in the fourth quarter. Sovran Advisors LLC now owns 1,118 shares of the financial services provider’s stock valued at $305,000 after purchasing an additional 38 shares during the period. Finally, Endowment Wealth Management Inc. grew its holdings in CME Group by 4.4% in the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after purchasing an additional 38 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Stock Up 0.2%
Shares of NASDAQ:CME opened at $267.79 on Friday. The stock has a 50-day simple moving average of $250.89 and a 200-day simple moving average of $281.05. The stock has a market capitalization of $96.29 billion, a P/E ratio of 22.71, a PEG ratio of 3.11 and a beta of 0.25. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.
CME Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were given a $1.30 dividend. The ex-dividend date of this dividend was Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. CME Group’s dividend payout ratio is presently 44.11%.
Insider Transactions at CME Group
In related news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the sale, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William R. Shepard purchased 325 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The shares were acquired at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the transaction, the director owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their position. The disclosure for this purchase is available in the SEC filing. Company insiders own 0.30% of the company’s stock.
Wall Street Analyst Weigh In
CME has been the topic of a number of recent analyst reports. Weiss Ratings downgraded shares of CME Group from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 13th. UBS Group decreased their price target on shares of CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a report on Monday, July 6th. Morgan Stanley boosted their price objective on shares of CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a research note on Thursday, July 23rd. Raymond James Financial restated an “outperform” rating and set a $320.00 price objective on shares of CME Group in a report on Thursday, July 2nd. Finally, TD Cowen cut their target price on CME Group from $323.00 to $273.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Eleven investment analysts have rated the stock with a Buy rating, four have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $291.81.
Read Our Latest Stock Report on CME
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Read More
- Five stocks we like better than CME Group
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
